Disease-A-Month
Volume 55, Issue 8 , Pages 476-526 , August 2009

The Multiple Organ Dysfunction Syndrome

References 

  1. Skillman JJ, Bushnell LS, Goldman H, et al. Respiratory failure, hypotension, sepsis and jaundice (A clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach). Am J Surg. 1969;117:523–530
  2. Tilney NL, Bailey GL, Morgan AP. Sequential system failure after rupture of abdominal aortic aneurysms: An unsolved problem in postoperative care. Ann Surg. 1973;178:117–122
  3. Baue AE. Multiple, progressive, or sequential systems failure. Arch Surg. 1975;110:779–781
  4. Eiseman B, Beart R, Norton L. Multiple organ failure. Surg Gynecol Obstet. 1977;144:323–326
  5. Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure: The role of uncontrolled infection. Arch Surg. 1980;115:136–140
  6. Goris RJA, te Boekhorst TPA, Nuytinck JKS, et al. Multiple-organ failure: Generalized autodestructive inflammation?. Arch Surg. 1985;120:1109–1115
  7. Meakins JL, Marshall JC. The gastrointestinal tract: The “motor” of MOF. Arch Surg. 1986;121:197–201
  8. Marshall J, Sweeney D. Microbial infection and the septic response in critical surgical illness. Arch Surg. 1990;125:17–23
  9. Meakins JL. Etiology of multiple organ failure. J Trauma. 1990;30(suppl):5165–5166
  10. Knaus A, Draper EA, Wagner DP, et al. Prognosis in acute organ system failure. Ann Surg. 1985;202:685–693
  11. American College of Chest Physicians/Society of Critical Care Medicine, Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874
  12. Marshall JC. The multiple organ dysfunction syndrome. In:  Holzheimer RG,  Mannick JA editor. Surgical Treatment: Evidence-based and problem-oriented. Munich: Zuckschwerdt Verlag; 2001;p. 780–785
  13. Ulvik A, Kvale R, Wentzel-Larsen T, et al. Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care. 2007;11:R95
  14. Barie PS, Hydo LJ. Epidemiology of multiple organ dysfunction syndrome in critical surgical illness. Surg Infect. 2000;1:173–186
  15. Barie PS, Hydo LJ. Influence of multiple organ dysfunction syndrome on duration of critical illness and hospitalization. Arch Surg. 1996;131:1318–1324
  16. Ciesla DJ, Moore EE, Johnson JL, et al. 12-Year prospective study of postinjury multiple organ failure: Has anything changed?. Arch Surg. 2005;40:432–440
  17. Barie PS, Hydo LJ, Shou J, et al. Decreasing magnitude of multiple organ dysfunction syndrome despite increasingly severe critical surgical illness: A 17-year longitudinal study. J Trauma. 2008;65:1227–1235
  18. Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008;133:1120–1127
  19. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310
  20. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34:344–353
  21. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8:776–787
  22. Warren HS. Toll-like receptors. Crit Care Med. 2005;33(suppl):S457–S459
  23. Bianchi ME, Dam Ps. PAMPs and alarmins: All we need to know about danger. J UK Biol. 2007;81:1–5
  24. Tang AM, Brunn GJ, Cascalho M, et al. Pivotal advance: Endogenous pathway to SIRS, sepsis, and related conditions. J Leukocyte Biol. 2007;82:282–285
  25. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: Pathophysiological consequences and underlying mechanisms. Clin Sci. 1998;94:461–471
  26. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and the coagulation system. Cardiovascular Res. 2003;60:26–39
  27. Bone RC. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996;125:680–687
  28. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001;163:316–321
  29. Cavaillon JM, Adib-Conquy M. Bench to bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care. 2006;10:233–239
  30. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest. 2007;117:289–296
  31. Miksa M, Wu R, Zhou M, et al. Sympathetic excitotoxicity in sepsis: Pro-inflammatory priming of macrophages by norepinephrine. Front Biosci. 2005;10:2217–2229
  32. Schmidt H, Muller-Werdan U, Hoffmann T, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005;33:1994–2002
  33. Godin PJ, Buchman TG. Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 1996;24:1107–1116
  34. Clark JA, Coopersmith CM. Intestinal crosstalk: A new paradigm for understanding the gut as the “motor” of crucial illness. Shock. 2007;28:384–398
  35. Fink MP. Intestinal epithelial hyperpermeability: Update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care. 2003;9:143–151
  36. Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of the multiple organ dysfunction syndrome in critically ill patients. Am J Respir Crit Care Med. 1999;158:444–451
  37. Kang W, Kudsk KA. Is there evidence that gut contributes to mucosal immunity in humans?. J Parenter Enteral Nutr. 2007;31:246–258
  38. Wolf HM, Fischer MB, Puhringer H, et al. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-α, interleukin-6) in human monocytes. Blood. 1994;83:1278–1288
  39. Fukatsu K, Sakamoto S, Hara E, et al. Gut ischemia-reperfusion affects gut mucosal immunity: A possible mechanism for infectious complications after severe surgical insults. Crit Care Med. 2006;34:182–187
  40. Alverdy JC, Spitz J, Hecht G, et al. Causes and consequences of bacterial adherence to mucosal epithelia during critical illness. New Horiz. 1994;2:264–272
  41. Alverdy JC, Laughlin RS, Wu L. Influence of the critically ill state on host–pathogen interactions within the intestine: Gut-derived sepsis redefined. Crit Care Med. 2003;31:598–607
  42. Alverdy J, Zoborina O, Wu L. The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr Opin Clin Nut Met Care. 2005;8:205–209
  43. Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60:126–133
  44. Magnotti LJ, Xu DZ, Lu Q, et al. Gut-derived mesenteric lymph: A link between burn and lung injury. Arch Surg. 1999;134:1333–1341
  45. Adams CA, Hauser CJ, Adams JM, et al. Trauma-hemorrhage-induced neutrophil priming is prevented by mesenteric lymph duct ligation. Shock. 2002;18:513–517
  46. Jordan JR, Moore EE, Sarin EL, et al. Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4. J Appl Physiol. 2008;104:1161–1166
  47. Yang S, Koo DJ, Zhou M, et al. Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during sepsis. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1274–G1281
  48. Powers KA, Szaszi K, Khadaroo RG, et al. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med. 2006;8:1951–1961
  49. Slutsky AS, Tremblay LN. Multiple system organ failure (Is mechanical ventilation a contributing factor?). Am J Respir Crit Care Med. 1998;157:1721–1725
  50. Uhlig S. Ventilation-induced lung injury and mechanotransduction: Stretching it too far?. Am J Physiol Lung Cell Molec Physiol. 2002;282:L892–L896
  51. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotraumas to biotrauma. Proc Assoc Am Physicians. 1998;110:482–488
  52. Tremblay LN, Slutsky AS. Ventilator-induced lung injury: from the bench to the bedside. Intens Care Med. 2006;32:24–33
  53. Ciesla DJ, Moore EE, Johnson RL, et al. The role of the lung in postinjury multiple organ failure. Surgery. 2005;138:749–758
  54. Moore FA, Moore EE, Sauaia A. Blood transfusion (An independent risk factor for postinjury multiple organ failure). Arch Surg. 1997;132:620–625
  55. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999;178:570–572
  56. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127:295–307
  57. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systemic review of the literature. Crit Care Med. 2006;36:2667–2674
  58. Balogh Z, McKinley BA, Cox CS, et al. Abdominal compartment syndrome: The cause or effect of postinjury multiple organ failure. Shock. 2003;20:483–492
  59. Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with postoperative organ failure: A redox theory. Arch Surg. 1983;118:1245–1251
  60. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care. 2004;8:462–468
  61. De Backer D, Creteur J, Preiser JC, et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98–104
  62. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825–1831
  63. Crouser ED, Julian MW, Dorinsky PM, et al. Ileal VO(2)-0(2) alterations induced by endotoxin correlate with severity of mitochondrial injury. Am J Respir Crit Care Med. 1999;160:1347–1353
  64. Porta F, Takala J, Weikert C, et al. Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Crit Care. 2006;10:R118
  65. Fink MP. Cytopathic hypoxia: Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 2001;17:219–237
  66. Exline MC, Crouser ED. Mitochondrial mechanisms of sepsis-induced organ failure. Front Biosci. 2008;13:5030–5041
  67. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424
  68. Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci. 2005;26:190–195
  69. Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet. 2004;364:545–548
  70. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219–223
  71. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, et al. Molecular signatures of sepsis: Multiorgan gene expression profiles of systemic inflammation. Am J Pathol. 2001;159:1199–1209
  72. Agarwal R, Srinivas R, Nath A, et al. Is the mortality higher in the pulmonary vs the extrapulmonary ARDS?: A metaanalysis. Chest. 2008;133:1463–1473
  73. Steinberg J, Halter J, Schiller HJ, et al. Metalloproteinase inhibition reduces lung injury and improves survival after caecal ligation and puncture in rats. J Surg Res. 2003;111:185–195
  74. Martin TR, Hagimoto N, Nakamura M, et al. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc. 2005;2:214–220
  75. Kolke K, Yamamoto Y, Hori Y, et al. Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion. Ann Surg. 2000;232:90–97
  76. Masclans JR, Sabater J, Sacanell J, et al. Possible prognostic value of leukotriene B4 in acute respiratory distress syndrome. Respir Care. 2007;52:1695–1700
  77. Schultz MJ, Haitsma JJ, Zhang H, et al. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—A review. Crit Care Med. 2006;34:871–877
  78. Poeze M, Ramsay G, Buurman WA, et al. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock. 2002;17:451–458
  79. Yang S, Zhou M, Chaudry IH, et al. Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of α2-adrenoreceptors. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1014–G1021
  80. Yang S, Koo DJ, Zhou KM, et al. Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol. 2000;279:G1274–G1281
  81. Aninat C, Sequin P, Descheemaeker PN, et al. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med. 2008;36:848–854
  82. Douzinas EE, Tsidemiadou PD, Pitaridis MT, et al. The regional production of cytokines and lactate in sepsis-related multiple organ failure. Am J Respir Crit Care Med. 1997;155:53–59
  83. Crouser ED, Julian MW, Huff J, et al. Carbamoyl phosphate synthase-1: A marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med. 2006;34:2439–2446
  84. Langenberg C, Bagshaw SM, May CN, et al. The histopathology of septic acute kidney injury: A systematic review. Crit Care. 2008;12:R38
  85. Langenberg C, Wan L, Egi M, et al. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69:1996–2002
  86. Wan L, Bagshaw SM, Langenberg C, et al. Pathophysiology of septic acute kidney injury: What do we really know. Crit Care Med. 2008;36(suppl):S198–S203
  87. Imai Y, Parodo J, Kajikawa O, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. J Am Med Assoc. 2003;289:2104–2112
  88. Steinvall I, Bak Z, Sjoberg F. Acute kidney injury is common, parallels organ dysfunction or failure, and carries appreciable mortality in patients with major burns: A prospective exploratory cohort study. Crit Care. 2008;12:R124
  89. Calvin JE, Driedger AA, Sibbald WJ. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest. 1981;80:579–586
  90. Merx MW, Weber C. Sepsis and the heart. Circulation. 2007;116:793–802
  91. Khadour FH, Panas D, Ferdinandy P, et al. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol Heart Circ Physiol. 2002;283:H1108–H1115
  92. Ferdinandy P, Danial H, Ambrus I, et al. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circul Res. 2000;87:241–247
  93. Soriano FG, Nogueira AC, Caldini EG, et al. Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit Care Med. 2006;34:1073–1079
  94. Levy RJ, Piel DA, Acton PD, et al. Evidence of myocardial hibernation in the septic heart. Crit Care Med. 2005;33:2752–2756
  95. Fernandes D, Assreuy J. Nitric oxide and vascular reactivity in sepsis. Shock. 2008;30:10–13
  96. Fernandes D, de Sordi R, Pacheco LK, et al. Late, but not early inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model. J Pharmacol Exp Ther. 2009;328:991–999
  97. Crawford JH, Chacko BK, Pruitt HM, et al. Transduction of NO-bioactivity by the red blood cell in sepsis: Novel mechanisms of vasodilation during acute inflammatory disease. Blood. 2004;104:1375–1382
  98. Kleinbongard P, Schulz R, Rassaf T, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood. 2006;107:2943–2951
  99. Diesen DL, Hess DT, Stamler JS. Hypoxic vasodilation by red blood cells (Evidence of an S-nitrosothiol-based signal). Circul Res. 2008;103:545–553
  100. Sharshar T, Hopkinson SN, Orlikowski D, et al. Science review: The brain in sepsis-culprit and victim. Crit Care. 2005;9:37–44
  101. FInelli PF, Uphoff DF. Magnetic resonance imaging abnormalities with septic encephalopathy. J Neurol Neurosurg Psychiatry. 2004;75:1189–1191
  102. Hopkins RO, Weaver LK, Pope D, et al. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:50–56
  103. Nguyen DN, Spapen H, Su F, et al. Elevated serum levels of S-100β protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med. 2006;34:1967–1974
  104. Jepson B, Freund HR, Gimmon Z, et al. Blood-barrier derangement in sepsis: Cause of septic encephalopathy?. Am J Surg. 1981;141:136–142
  105. Mizock BA, Sabelli HC, Dubin A, et al. Septic encephalopathy (Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy). Arch Intern Med. 1990;150:443–449
  106. Alexander JJ, Jacob A, Cunningham P, et al. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008;52:447–456
  107. Marshall JE, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–1652
  108. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intens Care Med. 1996;22:707–710
  109. Le Gall JR, Klar J, Lemeshow S, et al. The logistic organ dysfunction system (A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group). J Am Med Assoc. 1996;276:802–810
  110. Oda S, Hirasawa H, Sugai T, et al. Cellular injury score for multiple organ failure severity scoring system. J Trauma. 1998;45:304–311
  111. Bota DP, Melot C, Ferreira FL, et al. The multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (sofa) score in outcome prediction. Intens Care Med. 2002;28:1619–1624
  112. Timsit JF, Fosse JP, Troche G, et al. Calibration and discrimination by daily logistic organ dysfunction scoring comparatively with daily sequential organ failure assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med. 2002;30:2003–2013
  113. Oda S, Hirasawa H, Sugai T, et al. Comparison of sepsis-related organ failure assessment (SOFA) score and CIS (cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome. Intens Care Med. 2000;26:1786–1793
  114. Siegel JH, Giovannini I, Coleman B, et al. Pathologic synergy in cardiovascular and respiratory compensation with cirrhosis and sepsis: A manifestation of a common metabolic defect?. Arch Surg. 1982;117:225–238
  115. Villar J, Macao-Meyer N, Perez-Mendez L, et al. Bench-to-bedside review: Understanding genetic predisposition to sepsis. Crit Care. 2004;8:180–189
  116. Moore FA, Sauaia A, Moore EE, et al. Postinjury multiple organ failure: A bimodal phenomenon. J Trauma. 1996;40:501–512
  117. Ciesla DJ, Moore EE, Johnson JL, et al. Multiple organ dysfunction during resuscitation is not postinjury multiple organ failure. Arch Surg. 2004;139:590–595
  118. Cerra FB. The multiple organ failure syndrome. Hosp Pract. 1990;25:169–176
  119. Russell JA, Singer J, Bernard GR, et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med. 2000;28:3405–3411
  120. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery. 1987;101:1–14
  121. Makk LJK, McClave SA, Creech PW, et al. Clinical application of the metabolic cart to the delivery of total parenteral nutrition. Crit Care Med. 1990;18:1320–1327
  122. Mizock BA. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endo Metab. 2001;15:533–551
  123. Mizock BA. Metabolic derangements in sepsis and septic shock. Crit Care Clin. 2000;16:319–336
  124. Dunham CM, Fealk MH, Sever WE. Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care. 2003;7:R145–R153
  125. Cerra FB, Siegel JH, Coleman B, et al. Septic auto-cannibalism: A failure of exogenous nutritional support. Ann Surg. 1980;192:570–580
  126. Bongers T, Griffiths RD, McArdle A. Exogenous glutamine: The clinical evidence. Crit Care Med. 2007;35(suppl):S545–S552
  127. Kellum JA. Metabolic acidosis in patients with sepsis: Epiphenomenon or part of the pathophysiology?. Crit Care Resuscit. 2004;6:197–203
  128. Moviat M, van Haren F, van der Hoeven H. Conventional or physicochemical approach in intensive care unit patients with metabolic acidosis. Crit Care. 2003;7:R41–R45
  129. Forni LG, McKinnon W, Lord GA, et al. Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis. Crit Care. 2005;9:R591–R595
  130. Gando S, Satoshi N, Osamu K. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: Application of clinical decision analysis. Ann Surg. 1999;229:121–127
  131. Nguyen TC, Carcillo JA. Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure—A newly appreciated syndrome in the critically ill. Crit Care. 2006;10:235
  132. Brienza N, Dalfino L, Cinnella G, et al. Jaundice in critical illness: Promoting factors of a concealed reality. Intens Care Med. 2006;32:267–274
  133. Yap FHY, Joynt GM, Buckley TA, et al. Association of serum albumin concentration and mortality risk in critically ill patients. Anæsthesiol Intens Care. 2002;30:202–207
  134. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations. Crit Care Med. 2008;36:941–952
  135. Pinsky M, Vincent JL. Let us use the pulmonary artery catheter correctly and only when we need it. Crit Care Med. 2005;33:1119–1122
  136. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377
  137. Chytra I, Pradl R, Bosman R, et al. Esophageal Doppler-guided fluid management decreases blood lactate in multiple-trauma patients: A randomized controlled trial. Crit Care. 2007;11:R24
  138. Fiddian-Green RG. Splanchnic ischaemia and multiple organ failure in the critically ill. Ann R Coll Surg Eng. 1988;70:128–134
  139. Marik PE. Gastric intramucosal pH (A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis). Chest. 1993;104:225–229
  140. Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992;339:195–199
  141. Gomersall CD, Joynt GM, Freebairn RC, et al. Resuscitation of critically ill patients based on the results of gastric tonometry: A prospective randomized controlled trial. Crit Care Med. 2000;28:607–614
  142. Nakagawa Y, Weil MH, Tang W, et al. Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med. 1998;157:1838–1843
  143. Creteur J, De Backer D, Sakr Y, et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intens Care Med. 2006;32:516–523
  144. Crookes BA, Cohn SM, Bloch S, et al. Can near-infrared spectroscopy identify the severity of shock in trauma patients?. J Trauma. 2005;58:806–816
  145. Cohn SM, Nathens AB, Moore FA, et al. Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. J Trauma. 2007;62:44–55
  146. Ince C. Sidestream dark field imaging: An improved technique to observe sublingual microcirculation. Crit Care. 2005;9(suppl 1):72
  147. Mizock BA. Pathophysiology of hyperlactatemia. In:  Ronco C,  Bellomo R,  Kellum JA editor. Critical Care Nephrology. 2nd ed.. Philadelphia, PA: WB Saunders; 2009;p. 597–599
  148. Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41:989–1001
  149. Bakker J, Gris P, Coffernils M, et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221–226
  150. Manikis P, Jankowski S, Zhang H, et al. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med. 1995;13:619–622
  151. Abramson D, Scalea TM, Hitchcock R, et al. Lactate clearance and survival following injury. J Trauma. 1993;35:584–589
  152. Kincaid EH, Miller PR, Meredith JW, et al. Elevated arterial base deficit in trauma patients: A marker of impaired oxygen utilization. J Am Coll Surg. 1998;187:384–392
  153. Mikulaschek A, Henry SM, Donovan R, et al. Serum lactate is not predicted by anion gap or base excess after trauma. J Trauma. 1996;40:218–224
  154. Cheatham ML, Malbain ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome (II. Recommendations). Intens Care Med. 2007;33:951–962
  155. Hoyer D, Friedrich H, Zwiener U, et al. Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients. Int J Cardiol. 2006;108:359–369
  156. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327
  157. Levy B, Laure-Odile S, Gelot AM, et al. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28:114–119
  158. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94:1176–1186
  159. Bland RD, Shoemaker WC, Abraham E, Cobo JC. Hemodynamic and oxygen transport patterns in surviving and nonsurviving postoperative patients. Crit Care Med. 1985;13:85–90
  160. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients (SvO2 Collaborative Group). N Engl J Med. 1995;333:1025–1032
  161. Protti A, Singer M. Bench-to-bedside review: Potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10:228
  162. Abid O, Akca S, Haji-Michael P, et al. Strong vasopressor support may be futile in the intensive care unit patient with multiple organ failure. Crit Care Med. 2000;28:947–949
  163. Singer M. Catecholamine treatment for shock—Equally good or bad?. Lancet. 2007;370:636–637
  164. Polonen P, Ruokonen E, Hippelainen M, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052–1059
  165. Blow O, Magliore L, Claridge J, et al. The golden hour and the silver day: Detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma. 1999;47:964–969
  166. de Smet AMGA, Kluytmans JAJW, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20–31
  167. Dunne JR, Malone DL, Tracy JK, Napolitano LM. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect. 2004;5:395–404
  168. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. J Am Med Assoc. 2003;289:1941–1949
  169. Corwin HL. Anemia and blood transfusion in the critically ill patient: Role of erythropoietin. Crit Care. 2004;8(suppl 2):S42–S44
  170. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308
  171. Sakr Y, Vincent JL, Reinhart K, et al. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest. 2005;128:3098–3108
  172. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568–573
  173. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367
  174. Schetz M, Vanhorebeek I, Van den Berghe G. Insulin, glucose control and multiple organ dysfunction syndrome. J Organ Dysf. 2008;1:1–13
  175. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461
  176. Treggiari MM, Karir V, Yanez ND, et al. Intensive insulin therapy and mortality in critically ill patients. Crit Care. 2008;12:R29
  177. Krinsley SJ, Grover A. Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med. 2007;35:2262–2267
  178. van den Heuvel I, Ellger B. A sweet debate: Glycemic control in the intensive care unit. [Editorial] Crit Care Med. 2008;36:3271–3272
  179. Ligtenberg JJM, Zijlstra JG. The relative adrenal insufficiency syndrome revisited: Which patients will benefit from low-dose steroids. Curr Opin Crit Care. 2004;10:456–480
  180. Annane D, Sebille V, Charpentier C, Bollaert PE, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. J Am Med Assoc. 2002;288:862–871
  181. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124
  182. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–1949
  183. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–3777
  184. Bernard GR, Vincent JL, Laterre PF, et al. The recombinant human activated protein C worldwide evaluation in Severe Sepsis (PROWESS) Study Group. N Engl J Med. 2001;344:699–709
  185. Eichacker PQ, Natanson C. Increasing evidence that the risks of rhAPC may outweigh its benefits. [Editorial] Intens Care Med. 2007;33:396–399
  186. Kompan L, Kremzar B, Gadzijev E, et al. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intens Care Med. 1999;25:157–161
  187. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006;129:960–967
  188. Kreymann KG, Berger MM, Deutz NEP, et al. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nut. 2006;25:210–223
  189. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? (A systemic review of the evidence). J Am Med Assoc. 2001;286:944–953
  190. Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: When should we use dietary arginine supplementation?. Nutr Clin Pract. 2004;19:216–225
  191. Heyland DK, Dhaliwal R, Drover JW, et al. Canadian Critical Care Clinical Practice Guidelines Committee Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J Parenter Enteral Nutr. 2003;27:355–373
  192. Singer P, Shapiro H, Theilla M, et al. Anti-inflammatory properties of Omega-3 fatty acids in critical illness: Novel mechanisms and an integrative perspective. Intens Care Med. 2008;34:1580–1592
  193. Glatzle J, Kasparek MS, Mueller MH, et al. Enteral immunonutrition during sepsis prevents pulmonary dysfunction in a rat model. J Gastrointest Surg. 2007;11:719–724
  194. Pontes-Arruda A, Aragao AMA, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34:2325–2333
  195. Pontes-Arruda A, DeMichele S, Seth A, et al. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: A meta-analysis of outcome data. J Parenter Enteral Nutr. 2008;32:596–605
  196. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2032–2037
  197. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997;13:295–302
  198. Sakr Y, Reinhart K, Bloos F, et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anæsth. 2007;98:775–784
  199. Angstwurm MWA, Engelmann L, Zimmermann T, et al. Selenium in intensive care (SIC): Results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118–126
  200. Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis. Artif Organs. 2003;27:792–801
  201. Ratanarat R, Brendolan A, Piccinni P, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: Effects on hemodynamics and survival. Crit Care. 2005;9:R294–R302
  202. Spronk PE, Ince C, Gardien MJ, et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet. 2002;360:1395–1396
  203. Ince C. Microcirculation in distress: A new resuscitation end point?. Crit Care Med. 2004;32:1963–1964
  204. Protti A, Carre J, Frost MT, et al. Succinate recovers mitochondrial oxygen consumption in septic rat skeletal muscle. Crit Care Med. 2007;35:2150–2155
  205. Boulos M, Astiz ME, Barua RS, et al. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med. 2003;31:353–358
  206. Marshall JC. Iatrogenesis, inflammation and organ injury: Insights from a murine model. [Editorial] Crit Care. 2006;10:173–174
  207. Afessa B, Gajic O, Keegan MT. Severity of illness and organ failure assessment in adult intensive care units. Crit Care Clin. 2007;23:639–658
  208. Singer M. Mitochondrial function in sepsis: Acute phase versus multiple organ failure. Crit Care Med. 2007;35(suppl):S441–S448

PII: S0011-5029(09)00049-2

doi: 10.1016/j.disamonth.2009.04.002

Disease-A-Month
Volume 55, Issue 8 , Pages 476-526 , August 2009

Article Tools

* Image Usage & Resolution